Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. (Articolo in rivista)

Type
Label
  • Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. (Articolo in rivista) (literal)
Anno
  • 2005-01-01T00:00:00+01:00 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
  • 10.1038/sj.onc.1208562 (literal)
Alternative label
  • Sciamanna I.1, Landriscina M.2, Pittoggi C.3, Quirino M.4, Mearelli C.5, Beraldi R.6, Mattei E.7, Serafino A.8, Cassano A.9, Sinibaldi-Vallebona P.10, Garaci E.11, Barone C.12, Spadafora C.13 (2005)
    Inhibition of endogenous reverse transcriptase antagonizes human tumor growth.
    in Oncogene (Basingstoke)
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Sciamanna I.1, Landriscina M.2, Pittoggi C.3, Quirino M.4, Mearelli C.5, Beraldi R.6, Mattei E.7, Serafino A.8, Cassano A.9, Sinibaldi-Vallebona P.10, Garaci E.11, Barone C.12, Spadafora C.13 (literal)
Pagina inizio
  • 3923 (literal)
Pagina fine
  • 3931 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#altreInformazioni
  • Impact Factor (2005) = 6.495 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 24 (literal)
Rivista
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
  • 24 (literal)
Note
  • ISI Web of Science (WOS) (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • 1,3,5,13 = Istituto Superiore di Sanità, Rome, Italy; 2,4,9,12 = Medical Oncology Unit, Catholic University, Rome, Italy; 6 = Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Italy; 7 = CNR Institute of Molecular Biology and Pathology, Rome, Italy; 8 = CNR Institute of Neurobiology and Molecular Medicine, Rome, Italy; 10,11 = Department of Experimental Medicine and Biochemical Sciences, University 'Tor Vergata', Rome, Italy. (literal)
Titolo
  • Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. (literal)
Abstract
  • Undifferentiated cells and embryos express high levels of endogenous non-telomerase reverse transcriptase (RT) of retroposon/retroviral origin. We previously found that RT inhibitors modulate cell growth and differentiation in several cell lines. We have now sought to establish whether high levels of RT activity are directly linked to cell transformation. To address this possibility, we have employed two different approaches to inhibit RT activity in melanoma and prostate carcinoma cell lines: pharmacological inhibition by two characterized RT inhibitors, nevirapine and efavirenz, and downregulation of expression of RT-encoding LINE-1 elements by RNA interference (RNAi). Both treatments reduced proliferation, induced morphological differentiation and reprogrammed gene expression. These features are reversible upon discontinuation of the anti-RT treatment, suggesting that RT contributes to an epigenetic level of control. Most importantly, inhibition of RT activity in vivo antagonized tumor growth in animal experiments. Moreover, pretreatment with RT inhibitors attenuated the tumorigenic phenotype of prostate carcinoma cells inoculated in nude mice. Based on these data, the endogenous RT can be regarded as an epigenetic regulator of cell differentiation and proliferation and may represent a novel target in cancer therapy. (literal)
Prodotto di
Autore CNR
Insieme di parole chiave

Incoming links:


Prodotto
Autore CNR di
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
Insieme di parole chiave di
data.CNR.it